what is a glp 1 medication America's Poison Centers GLP-1 Medications Show Promise as

J Biol Chem (1983) 258:32804

Weight loss is a complex medical process that should always involve professional guidance

Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Amgen, Inc.

The primary end point was steroid use, with secondary end points including all-cause hospitalization, Crohns diseaserelated surgery, and persistence with advanced inflammatory bowel disease (IBD) therapy

doi: 10.1128/mcb.16.1.19

#Cardiology #ASCVD #ClinicalResearch #CardiovascularRisk #Obesity #EvidenceBasedMedicine #PrecisionMedicine Evolocumab can help attenuate the elevated risk of major adverse cardiovascular events that individuals with obesity and atherosclerotic cardiovascular disease (ASCVD) face, according to a prespecified analysis from the FOURIER trial published in #JACC